Reducing Cesarean Delivery Surgical Site Infections: A Resident-Driven Quality Initiative.
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
12
1
2019
medline:
16
11
2019
entrez:
12
1
2019
Statut:
ppublish
Résumé
To examine the association of a resident-driven quality initiative with cesarean delivery surgical site infections. This was a quasi-experimental, preintervention and postintervention study of women undergoing cesarean delivery at 23 weeks of gestation or greater between January 2015 and June 2018 at a single tertiary care center. We implemented a resident-driven, evidence-based surgical bundle, excluding women who underwent emergency cesarean or had chorioamnionitis. The bundle included routine prophylactic antibiotics (both cefazolin and azithromycin), chlorhexidine alcohol skin preparation, use of clippers instead of a razor, vaginal cleansing with povidone iodine, placental removal by umbilical cord traction, subcutaneous tissue closure if wound thickness greater than 2 cm, suture skin closure, dressing removal between 24 and 48 hours, and use of postoperative chlorhexidine soap. Our primary outcome was surgical site infections (superficial incisional, deep incisional, and organ or space surgical site infections) occurring up to 6 weeks postpartum. Outcomes were compared between the preimplementation period (January 2015-August 2016) and postimplementation period (December 2016-June 2018). Coarsened Exact Matching with k-to-k solution was performed using age, race-ethnicity, body mass index, rupture of membranes, and labor. In total, 1,624 underwent cesarean delivery in the preimplementation and 1,523 postimplementation periods, respectively; 1,100 women in the postimplementation period were matched to 1,100 women in the preimplementation period. The rate of surgical site infections in the unmatched cohort was significantly lower in the postimplementation period compared to those in the preimplementation period (2.2% [33/1,523] vs 4.5% [73/1,624]; odds ratio [OR] 0.47 [95% CI 0.31-0.71]; P<.001). This decrease in the rate of surgical site infections remained statistically significant after matching (1.9% [21/1,100] vs 4.1% [45/1,100]; OR 0.46 [0.27-0.77]; P<.001). After implementation of a resident-driven quality initiative using a surgical bundle, we observed a significant decrease in cesarean surgical site infections.
Identifiants
pubmed: 30633146
doi: 10.1097/AOG.0000000000003091
pmc: PMC6353635
mid: NIHMS1517775
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-288Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001409
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HD999999
Pays : United States
Références
Am J Obstet Gynecol. 2008 Sep;199(3):301.e1-6
pubmed: 18771991
Am J Obstet Gynecol. 2010 Mar;202(3):310.e1-6
pubmed: 20207251
Am J Obstet Gynecol. 2017 Oct;217(4):449.e1-449.e9
pubmed: 28601567
Obstet Gynecol. 2012 Aug;120(2 Pt 1):246-51
pubmed: 22825081
Obstet Gynecol. 2008 Jan;111(1):51-6
pubmed: 18165392
Obstet Gynecol. 2017 Mar;129(3):481-485
pubmed: 28178058
Am J Perinatol. 2015 Jul;32(9):825-32
pubmed: 25594218
Cochrane Database Syst Rev. 2018 Jul 17;7:CD007892
pubmed: 30016540
Obstet Gynecol. 2017 Oct;130(4):735-746
pubmed: 28885421
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004737
pubmed: 18646109
Obstet Gynecol. 2004 May;103(5 Pt 1):974-80
pubmed: 15121573
Natl Vital Stat Rep. 2018 Jan;67(1):1-55
pubmed: 29775434
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96
pubmed: 10196487
N Engl J Med. 2016 Sep 29;375(13):1231-41
pubmed: 27682034
Obstet Gynecol. 2004 May;103(5 Pt 1):907-12
pubmed: 15121564
BJOG. 2016 May;123(6):983-93
pubmed: 26412384
Matern Health Neonatol Perinatol. 2017 Jul 5;3:12
pubmed: 28690864
Obstet Gynecol. 2014 Jun;123(6):1169-75
pubmed: 24807325
Obstet Gynecol. 2016 Jun;127(6):1135-44
pubmed: 27159744
J Am Coll Surg. 2013 Jan;216(1):23-33
pubmed: 23127793
Cochrane Database Syst Rev. 2011 Nov 09;(11):CD004122
pubmed: 22071812
Infect Control Hosp Epidemiol. 2010 Aug;31(8):872-5
pubmed: 20583923
Obstet Gynecol. 2003 Feb;101(2):289-96
pubmed: 12576252
N Engl J Med. 2016 Feb 18;374(7):647-55
pubmed: 26844840
JAMA Surg. 2014 Oct;149(10):1045-52
pubmed: 25163027
Obstet Gynecol. 2016 Mar;127(3):426-36
pubmed: 26855098
Am J Obstet Gynecol. 2016 Sep;215(3):388.e1-5
pubmed: 27018465